Helle Frank, Hultström Michael, Skogstrand Trude, Palm Fredrik, Iversen Bjarne M
Renal Research Group, Institute of Medicine, University of Bergen, N-5021 Bergen, Norway.
Am J Physiol Renal Physiol. 2009 Jan;296(1):F78-86. doi: 10.1152/ajprenal.90518.2008. Epub 2008 Oct 22.
Two-kidney, one-clip (2K1C) is a model of renovascular hypertension where we previously found an exaggerated intracellular calcium (Ca(i)(2+)) response to ANG II in isolated afferent arterioles (AAs) from the clipped kidney (Helle F, Vagnes OB, Iversen BM. Am J Physiol Renal Physiol 291: F140-F147, 2006). To test whether nitric oxide (NO) ameliorates the exaggerated ANG II response in 2K1C, we studied ANG II (10(-7) mol/l)-induced calcium signaling and contractility with or without the NO synthase (NOS) inhibitor N(G)-nitro-l-arginine methyl ester (l-NAME). In AAs from the nonclipped kidney, l-NAME increased the ANG II-induced Ca(i)(2+) response from 0.28 +/- 0.05 to 0.55 +/- 0.09 (fura 2, 340 nm/380 nm ratio) and increased contraction from 80 +/- 6 to 60 +/- 6% of baseline (P < 0.05). In vessels from sham and clipped kidneys, l-NAME had no effect. In diaminofluorescein-FM diacetate-loaded AAs from the nonclipped kidney, ANG II increased NO-derived fluorescence to 145 +/- 34% of baseline (P < 0.05 vs. sham), but not in vessels from the sham or clipped kidney. Endothelial NOS (eNOS) mRNA and ser-1177 phosphorylation were unchanged in both kidneys from 2K1C, while eNOS protein was reduced in the clipped kidney compared with sham. Cationic amino acid transferase-1 and 2 mRNAs were increased in 2K1C, indicating increased availability of l-arginine for NO synthesis, but counteracted by decreased scavenging of the eNOS inhibitor asymmetric dimethylarginine by dimethylarginine dimethylaminohydrolase 2. In conclusion, the Ca(i)(2+) and contractile responses to ANG II are blunted by NO release in the nonclipped kidney. This may protect the nonclipped kidney from the hypertension and elevated ANG II levels in 2K1C.
两肾一夹(2K1C)是一种肾血管性高血压模型,我们之前发现,在来自夹闭肾的分离入球小动脉(AA)中,细胞内钙(Ca(i)(2+))对血管紧张素II(ANG II)的反应过度(Helle F,Vagnes OB,Iversen BM。《美国生理学杂志:肾脏生理学》291:F140 - F147,2006)。为了测试一氧化氮(NO)是否能改善2K1C中过度的ANG II反应,我们研究了在有或没有一氧化氮合酶(NOS)抑制剂N(G)-硝基-L-精氨酸甲酯(L-NAME)的情况下,ANG II(10(-7) mol/l)诱导的钙信号传导和收缩性。在来自未夹闭肾的AA中,L-NAME使ANG II诱导的Ca(i)(2+)反应从0.28±0.05增加到0.55±0.09(fura 2,340 nm/380 nm比值),并使收缩从基线的80±6%增加到60±6%(P < 0.05)。在假手术和夹闭肾的血管中,L-NAME没有影响。在来自未夹闭肾的二氨基荧光素 - FM二乙酸酯负载的AA中,ANG II使NO衍生的荧光增加到基线的145±34%(与假手术相比,P < 0.05),但在假手术或夹闭肾的血管中没有增加。在2K1C的两个肾脏中,内皮型NOS(eNOS)mRNA和丝氨酸1177磷酸化均未改变,而与假手术相比,夹闭肾中的eNOS蛋白减少。阳离子氨基酸转运体-1和2的mRNA在2K1C中增加,表明用于NO合成的L-精氨酸可用性增加,但被二甲基精氨酸二甲胺水解酶2对eNOS抑制剂不对称二甲基精氨酸清除减少所抵消。总之,在未夹闭肾中,NO释放使对ANG II的Ca(i)(2+)和收缩反应减弱。这可能保护未夹闭肾免受2K1C中的高血压和升高的ANG II水平的影响。